Capecitabine and streptozocin ± cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trial

Documenti analoghi

• Gastroenteropancreatic neuroendocrine tumours.
  di: Modlin, I, et al.
  Pubblicazione: (2008)
• Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).
  di: Ramage, J, et al.
  Pubblicazione: (2012)
• An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology.
  di: Chetty, R
  Pubblicazione: (2008)
• A rare case of hepatic flexure Gastroenteropancreatic neuroendocrine carcinoma (GEP-NEC)
  di: Jasmani, Asraf Haslam, et al.
  Pubblicazione: (2022)
• The relationship of survivin expression with tumour grade in gastroenteropancreatic neuroendocrine tumour (GEPNET)-USM experience
  di: Hazmi, Hilma
  Pubblicazione: (2018)